title: Association Between Inflammatory Bowel Disease and Erectile Dysfunction: A Nationwide Population-Based Study.
abstract: BACKGROUND
  To determine whether inflammatory bowel disease (IBD) is associated with an increased risk of subsequent erectile dysfunction (ED).
  
  
  METHODS
  We identified 1845 patients who received a diagnosis with IBD between 2000 and 2011 from Taiwan's National Health Insurance Research Database. For the comparison cohort, we randomly extracted the data of 7380 patients matched by sex, age, and baseline year. Follow-up continued until the development of ED, withdrawal from the National Health Insurance program, or the end of 2011. The cumulative incidences and hazard ratios (HRs) for ED development were determined.
  
  
  RESULTS
  After 12 years of follow-up, subsequent ED incidence rates in the IBD and comparison cohorts were 2.23 and 1.29 per 10,000 person-years, respectively (adjusted hazard ratio = 1.64; 95% confidence interval [CI], 1.07-2.52; P < 0.05). Compared with the non-IBD cohort without comorbidity, the risk of ED was higher in the IBD cohort with comorbidity (adjusted hazard ratio = 2.46, 95% CI, 1.32-4.58). Patients with ulcerative colitis were 2.27-fold more likely to develop ED than were patients without IBD (95% CI, 1.22-4.20). Compared with patients without IBD who were aged ≤49 years, patients with IBD aged ≥65 years were 3.36-fold more likely to develop ED (95% CI, 1.42-7.96).
  
  
  CONCLUSIONS
  We found that the patients with IBD had a 1.64-fold higher risk of developing ED than did the comparison group. Physicians should be aware of the link to ED when assessing patients with IBD.
authors: *Division of Urology, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan; †Management Office for Health Data, China Medical University Hospital, Taichung, Taiwan; ‡College of Medicine, China Medical University, Taichung, Taiwan; §Department of Radiation Oncology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan; ‖Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan; ¶Division of Infectious disease, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan; **Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan; ††Graduate Institute of Clinical Medicine Science and School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan; and ‡‡Department of Nuclear Medicine and PET Center, China Medical University Hospital, Taichung, Taiwan.
authors: Chien-Chang
authors: CC
authors: Kao
authors: Cheng-Li
authors: CL
authors: Lin
authors: Wen-Yen
authors: WY
authors: Huang
authors: Tai-Lung
authors: TL
authors: Cha
authors: Te-Yu
authors: TY
authors: Lin
authors: Chih-Hao
authors: CH
authors: Shen
authors: Chia-Hung
authors: CH
authors: Kao
mesh_terms: D000328:Adult; D000368:Aged; D015331:Cohort Studies; D015897:Comorbidity; D007172:Erectile Dysfunction / Q000453:epidemiology / Q000209:etiology* / Q000473:pathology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D015212:Inflammatory Bowel Diseases / Q000150:complications*; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D012307:Risk Factors; D013624:Taiwan / Q000453:epidemiology